Crossref
Subcutaneous methotrexate for treating rheumatoid arthritis in Portugal: a cost-utility analysis versus current practice
ARP Rheumatology · 2026
DOI: 10.63032/clnt5799 ↗Kurz gefasst
Fachartikel in der Zeitschrift ARP Rheumatology, 2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Subcutaneous methotrexate for treating rheumatoid arthritis in Portugal: a cost-utility analysis versus current practice. ARP Rheumatology. https://doi.org/10.63032/clnt5799
Vancouver
Subcutaneous methotrexate for treating rheumatoid arthritis in Portugal: a cost-utility analysis versus current practice. ARP Rheumatology. 2026. doi:10.63032/clnt5799
BibTeX
@article{euvimed2026,
title = {Subcutaneous methotrexate for treating rheumatoid arthritis in Portugal: a cost-utility analysis versus current practice},
journal = {ARP Rheumatology},
year = {2026},
doi = {10.63032/clnt5799}
}
EUVIMED